PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-53

  1. 353 Posts.
    lightbulb Created with Sketch. 399
    Generally, not a maintained website. Can always tell when they stop updating dates. Copyright © 2022
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.